Skip to content

MyAI Registry for People with Adrenal Insufficiency

Search Clinical Trials

Trial Objectives

To help better understand adrenal insufficiency (AI) and its progression, researchers have developed a new registry called MyAI. Information collected via online surveys for the registry will help researchers learn about patient experiences with the illness and how it is impacting their lives. Researchers also will use the data to assess the effectiveness of current treatments and identify common causes and risk factors for AI. Adults, as well as children from birth to age 18, who have been diagnosed with AI or who are at high risk of developing the disease are needed to participate in the registry.

Who Can Participate

Group 1: People with known adrenal insufficiency

Group 2: At-risk of adrenal insufficiency due to drug treatments, family history or autoimmune disease

Group 3: Control group. People with no adrenal disease or family history of adrenal disease, and people who have not been treated with high-risk drugs such as prednisone, dexamethasone or opiates

Age: All Ages Gender Any

Estimated Time Commitment

Initial online survey will take 30 minutes. Follow-up surveys every six months will take five to 10 minutes. Total time involvement is 10-20 years.

Payment & Reimbursement

Payment Not Provided

Travel Reimbursement Not Available

Trial Contact

For more information, contact:

Whit Hover

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

National Adrenal Diseases Foundation

Principal Investigators

Elizabeth Anne Regan

Elizabeth Anne Regan, MD, PhD

Request more Information

By completing this form, you agree to learn more about this study and see if you qualify.

I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health required